Cornell Cancer Center — New York, New York

Cornell Cancer Center is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Cornell Cancer Center has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies.

Sponsors: Institut de Recherches Internationales Servier.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cornell Cancer Center?

Cornell Cancer Center has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cornell Cancer Center conducted?

Cornell Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed or Refractory Acute Myeloid Leukemia (AML), Untreated AML, Other IDH1-mutated Positive Hematologic Malignancies.

Is Cornell Cancer Center accredited by Crixeo Health?

Cornell Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Cornell Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.